Europe Heart Failure Drugs market

Western-europe accounted for the largest market share in 2018 in the europe heart failure drugs market, and is expected to reach usd 3248.45 million in 2025 from usd 1012.25 million in 2018. however, italy is the fastest growing market, which is expected to grow at a cagr of 19.15% during the forecast period 2019 - 2025. speciality centers segment accounted for the largest market share in 2018, this market is expected to reach usd 1647.93 million in 2025 from usd 485.74 million in 2018. this market is projected to grow at a cagr of 19.45% during the forecast period from 2019 - 2025. however, speciality centers segment is the fastest growing market, which is expected to grow at a cagr of 19.45% during the forecast period 2019 - 2025. angiotensin receptor neprilysin inhibitors segment accounted for the largest market share in 2018, this market is expected to reach usd 1091.91 million in 2025 from usd 321.76 million in 2018. this market is projected to grow at a cagr of 19.45% during the forecast period from 2019 - 2025. however, angiotensin receptor neprilysin inhibitors segment is the fastest growing market, which is expected to grow at a cagr of 19.45% during the forecast period 2019 - 2025.